Latest papers

Chronic hepatitis C treatment in a cystic fibrosis patient in the pulmonary pre-transplant stage.

Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.

Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma.

Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

The N-terminus of Bunyamwera orthobunyavirus NSs protein is essential for interferon antagonism.

Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance.

[Interferon caused dysfunction of thyroid in chronic hepatitis C patient: a case report].

Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.

Accessory protein 5a is a major antagonist of the antiviral action of interferon against murine coronavirus.

Pulmonary-renal syndrome in hepatitis C infection and rheumatoid arthritis.

Psychiatric side effects of non-psychiatric drugs.

A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy.

Microarray approach reveals the relevance of interferon signaling pathways with rat liver restoration post 2/3 hepatectomy at cellular level.

Interferons modulate mitogen-induced protein synthesis in airway smooth muscle.

Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.

Unpaired 5' ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I.

Commentary: Scheme has benefited patients

Using cytokines to treat cervical intraepithelial and invasive neoplasia.

Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US.

[Responsive factors and predictors of interferon treatment in patients with chronic hepatitis B].